Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Assets (2021 - 2025)

Historic Return on Assets for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 0.61%.

  • Verrica Pharmaceuticals' Return on Assets rose 14000.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year increase of 14000.0%. This contributed to the annual value of 1.09% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, Verrica Pharmaceuticals' Return on Assets stood at 0.61%, which was up 14000.0% from 1.15% recorded in Q2 2025.
  • Verrica Pharmaceuticals' Return on Assets' 5-year high stood at 0.34% during Q2 2023, with a 5-year trough of 2.0% in Q3 2024.
  • For the 5-year period, Verrica Pharmaceuticals' Return on Assets averaged around 0.87%, with its median value being 0.61% (2022).
  • Per our database at Business Quant, Verrica Pharmaceuticals' Return on Assets plummeted by -14000bps in 2024 and then surged by 14000bps in 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Return on Assets (Quarter) stood at 0.42% in 2021, then decreased by -18bps to 0.49% in 2022, then plummeted by -53bps to 0.75% in 2023, then tumbled by -127bps to 1.7% in 2024, then soared by 64bps to 0.61% in 2025.
  • Its Return on Assets was 0.61% in Q3 2025, compared to 1.15% in Q2 2025 and 1.32% in Q1 2025.